Introduction
During mid-gestation, the placenta gradually matures and provides embryos with oxygen and nutrition more efficiently, 1 which makes it possible for the embryo to enter a rapid growth stage. To address the dramatic increase in the circulatory system load of the rapidly growing embryo, heart development shifts from cardiac patterning to cardiac growth and chamber maturation, 2 which enhances cardiac contractile performance. 3 Although cardiomyocyte proliferation is the major determinant of cardiac size during prenatal stage, 2 well-organized cardiac cytoarchitecture within the ventricle is critical for the contractile performance of the heart. 4, 5 The polyhedral-shaped embryonic cardiomyocytes connect with each other along their entire circumference to build the mechanical and electrical integration with neighbouring cardiomyocytes. 6, 7 Genetic studies in mice have demonstrated that impairing cardiac cytoarchitecture affects normal embryonic heart development during mid-gestation. For example, the inactivation of cell junction proteins, such as N-cadherin, vinculin, plakoglobin, and plakophilin, led to embryonic lethality from E10.0 to E16.5 with severe heart defects. [8] [9] [10] [11] [12] Wnt11 deletion, which disrupts the expression pattern of N-cadherin and b-catenin, also results in cardiac dysfunction and eventual lethality after E12. 5 . 13 However, the underlying signals that regulate the establishment of cytoarchitecture in the developing heart, especially during midgestation, are still largely unknown. Previous studies have reported that small GTPases, including Rap1, Rho GTPases, and Rab GTPases, regulate cell-cell junctions in different types of cells [14] [15] [16] and are required for heart morphogenesis. [17] [18] [19] [20] The activity of small GTPases requires not only GTP binding but also membrane attachment, which is mediated by protein prenylation. 21 Protein prenylation is a post-translational lipidation that facilitates the membrane localization of intracellular proteins by attaching a farnesyl or geranylgeranyl group to the cysteine residues at or near the carboxyl terminus. 21, 22 Notably, farnesyl pyrophosphate (FPP) or geranylgeranyl pyrophosphate (GGPP), which are two types of isoprenoids that are involved in protein prenylation, are intermediates derived from the mevalonate pathway. 21 Genetic evidence showed that the inactivation of HMG-CoA reductase (a key upstream enzyme in the mevalonate pathway) and geranylgeranyl pyrophosphate synthase (Ggpps, a branch point enzyme in the mevalonate pathway that converts FPP to GGPP) or the pharmacological inhibition of prenyltransferases disrupt heart formation in Drosophila and affect myocardial migration and heart tube formation in zebrafish. 23, 24 Our previous study has shown that protein prenylation is involved in the hypertrophy growth of cardiomyocytes at the post-natal stage. 25 Thus, these studies implicate a relationship between protein prenylation and heart development. However, the exact function of protein prenylation in mammalian embryonic heart development is still unknown. Our recent study demonstrated that GGPPS could modulate the balance of protein prenylation in the heart. 25 Thus, targeting Ggpps is a useful strategy to study the function of protein prenylation in organ development. In this study, we found that cardiac Ggpps gene expression was augmented after E10. 5 . Therefore, we reasoned that GGPPSmediated protein geranylgeranylation might play an important role for heart development during mid-gestation. By inactivating Ggpps at different embryonic stages of heart development using different Cre lines, we confirmed that protein geranylgeranylation was required for the ventricular chamber maturation and serves a novel stage-specific signal to regulate the organization of cardiomyocytes during mid-gestation.
Methods
Please see also the detailed materials and methods description in the Supplementary material online. Table S3 . Apoptosis was assessed using a florescent kit purchased from Promega (#G3250).
Mice

Total RNA isolation and q-PCR
Total RNA was isolated from embryonic hearts using Trizol reagent (Takara), and cDNA was synthesized with the PrimeScript TM RT Master Mix (Takara) according to the manufacturer's protocol. Quantitative PCR was performed with the SYBR TM Select Master Mix (Applied Biosystems) using the Applied Biosystems 7300 Real-Time PCR system. Rplp0 and Gapdh were used as an internal control. The primer sequences used in q-PCR are listed in Supplementary material online, Table S4 .
Immunoblot analysis and immunoprecipitation
For immunoblot analysis, embryonic hearts were homogenized in 1Â SDS-PAGE sample buffer and boiled for 5 min. Proteins were separated on an SDS-PAGE gel and transferred to a polyvinylidene difluoride (PVDF) membrane (Roche). Membranes were blocked and incubated with the indicated primary antibody overnight at 4 C. Bound primary antibodies were detected by HRP-conjugated secondary antibodies and a chemiluminescent substrate. For immunoprecipitation, embryonic hearts were homogenized in IP buffer and the lysates were centrifuged. The supernatant was incubated with the indicated primary antibody overnight at 4 C. The immune complexes were immunoprecipitated using protein A/G agarose beads (Santa Cruz, #sc-2003). Primary antibodies used in the immunoblot analysis and immunoprecipitation are listed in Supplementary material online, Table S3 .
Cell culture
The HeLa cell line [ATCC (CCL-2)] was maintained in DMEM containing 10% FBS and antibiotics under standard conditions. Primary cardiomyocytes were isolated from E11.5 hearts. The digested cells were plated on gelatin coated cover slide in DMEM containing 10% FBS and antibiotics under standard conditions. After genotyping, control and Ggpps deficient cardiomyocytes were treated with vehicle or GGPP (Sigma, #G6025).
Transmission electron microscopy
Hearts isolated from embryos were fixed in 2.5% glutaraldehyde, postfixed in 1% osmium tetroxide, dehydrated in a graded series of acetone, and then embedded in Epon resin. 
Triton X-114 extraction of hydrophobic proteins
Hydrophobic and hydrophilic proteins were purified using Triton X-114 extraction to determine the membrane localization of small GTPase. Briefly, embryonic hearts were homogenized in Triton X-114 lysis buffer and the lysates were centrifuged. The supernatant was incubated at 37 C for 5 min until the lysate became turbid and was centrifuged at 12 000 g for 5 min at room temperature. The upper phase was an aqueous phase containing hydrophilic proteins (water-soluble small G protein), and the lower phase was a detergent phase containing hydrophobic proteins (lipid-soluble small G protein).
Small GTPase activity assay
Five E10.5 control and Nkx2.5 Cre/þ ; Ggpps fl/fl hearts were pooled as a sample and the whole heart lysate was used for subsequent assay. RhoA and Rac1 activity were determined using a kit purchased from NewEast Biosciences (Catalog #80601 and 80501).
Statistical analysis
All data were presented as the mean ± SEM and were analysed using an unpaired two-tailed Student's t-test between two groups. Multiple groups were tested by one-way ANOVA with Dunnett post-hoc test or two-way ANOVA followed by Bonferroni post-hoc test. P < 0.05 was considered to be statistically significant. All statistical results were performed using origin8.0 and GraphPad Prism5 software.
Results
The expression of Ggpps increased in a stage-dependent manner in the developing heart
To address whether protein prenylation played a role in mammalian heart development, we first detected the expression pattern of Ggpps in mouse embryonic hearts. We found that GGPPS was expressed in both atria and ventricles continuously from E8.5 to E18.5, but its expression was lower in the endocardial cushion than the compact zone and trabeculae ( Figure 1A) . We also compared the Ggpps expression level among different organs. The protein and mRNA level of Ggpps in the heart were higher compared to the lung and liver ( Figure 1A and see Supplementary material online, Figure S1 ). Furthermore, the mRNA and protein levels of Ggpps in the heart were upregulated from E10.5 to E13.5 ( Figure 1B-C) . These data suggested that Ggpps was highly expressed in the heart in a stagedependent manner.
3.2
Stage-specific disruption of protein geranylgeranylation in embryonic cardiomyocytes by Nkx2.5 Cre/þ and a-SMA-Cre lines
To demonstrate the stage-specific functions of Ggpps-mediated protein geranylgeranylation in mammalian heart development, we used Nkx2.5
Cre/þ and a-SMA-Cre lines to delete Ggpps in embryonic cardiomyocytes. Nkx2.5-Cre was restricted to express within cardiac progenitors at approximately E7. 5 . 26 Here, we crossed Nkx2.5
Cre/þ mice with Rosa26 mT/mG reporter mice and found the GFP signal in the heart region at as early as E8.5 [see Supplementary material online, Figure S2A (a-c)].
We also confirmed that Cre-mediated recombination was hardly detectable in the endocardial cushion, endocardium or epicardium at E11. 5 [see Supplementary material online, Figure S2A (c')]. a-SMA-Cre was only expressed in differentiated cardiomyocytes from E9.5 onwards. 28 Our
Cre lineage tracing results showed that there was no GFP signal in the a-SMA-Cre; Rosa26 mT/mG embryo including heart region at E8.5 [see Supplementary material online, Figure S2B (a)]. From E9.5 onwards, GFP expression was gradually detectable in the heart region [see Supplementary material online, Figure S2B (b-g)]. At E13.5 and E15.5, a-SMA-Cre mediated recombination could be detected in around 70% and 87% cardiomyocytes, respectively, (see Supplementary material online, Figure S2C ). The knockout efficiency of Ggpps was also confirmed in these two animal models by q-PCR, immunoblot, and immunohistochemistry. As shown in Supplementary material online, Figure S3 , Ggpps had been deleted in E9.5 Nkx2.5
Cre/þ ; Ggpps fl/fl hearts and E13.5 a-SMA-Cre;
Ggpps fl/fl hearts, respectively. Because GGPPS facilitates protein prenylation by providing GGPP, we further examined the exact time point when protein prenylation was altered in these two different mutant models. Rap1A, which is one representative geranylgeranylated protein, was detected by an anti-unprenylated Rap1A antibody to measure protein geranylgeranylation indirectly. 29 Notably, unprenylated Rap1A was detected in Nkx2.5
Cre/þ
; Ggpps fl/fl hearts as early as E9.5 (see Supplementary material online, Figure S4A ), whereas no obvious band of unprenylated Rap1A was found in a-SMA-Cre; Ggpps fl/fl hearts until E13.5 (see Supplementary material online, Figure S4B ). Although we cannot exclude the possibility that protein geranylgeranylation has been disrupted before E9.5 in Nkx2.5
; Ggpps fl/fl hearts, these results, at least, confirmed that the inactivation of Ggpps by Nkx2.5
Cre/þ and a-SMA-
Cre could disrupt protein geranylgeranylation in mouse heart by E9.5 and E13.5, respectively.
Cardiac inactivation of Ggpps by
Nkx2.5 Cre/þ affected ventricular chamber maturation and resulted in embryonic lethality
No viable Nkx2.5 Cre/þ ; Ggpps fl/fl progenies were born, which suggested mutant embryos died in utero (see Supplementary material online, Table  S1 ). Timed intercross and genotyping of embryos from different developmental stages confirmed that most of the Nkx2. Table S1 and Figure 2A ). Further gross morphological examination demonstrated that all Nkx2.5 Cre/þ ; Ggpps fl/fl embryos appeared normal compared to control littermates at E10.5 and E11.5 ( Figure 2B ). However, at E12.5, 49 Nkx2.5 Cre/þ ; Ggpps fl/fl embryos (88 total) showed pericardial effusion and haemorrhage in the liver and vessels ( Figure 2B ), which indicated a failure of the circulation system. The gross morphology analysis showed that E12.5 Nkx2.5 Cre/þ ; Ggpps fl/fl hearts had a smaller size than control hearts and lost the structure of interventricular groove (see Supplementary material online, Figure S5A ). Further histological analysis revealed that trabeculae area, but not ventricular wall thickness, was significantly reduced in Nkx2.5 Cre/þ ; Ggpps fl/fl hearts compared to control hearts at E11.5 and E12.5 ( Figure 2C and see Supplementary material online, Figure S5B -D). In addition, the poorly developed interventricular septum was observed in E12.5 Nkx2.5
Cre/þ ; Ggpps fl/fl hearts ( Figure 2C ). More importantly, we
found that the number of cardiomyocytes (marked by cTnT) was Figure 2D and E). These observations suggested that Ggpps was required for the growth of ventricular chamber.
To demonstrate the reason of cardiac growth arrest in Nkx2.5 Cre/þ ; Ggpps fl/fl embryos, we conducted an analysis of cell proliferation. Ki67
and phosphorylated histone H3 (pHH3) staining showed no significant differences in the proliferative rate between control and Nkx2.5 Cre/þ ; Ggpps fl/fl hearts at E10.5 ( Figure 2F-I) . At E11.5, the number of Ki67-positive cardiomyocytes was still not changed ( Figure 2F and G), but pHH3-positive staining of cardiomyocytes was decreased in Nkx2.5 Cre/þ ; Ggpps fl/fl hearts compared to control hearts ( Figure 2H and I). At E12.5, more severe proliferation defects were observed, which was demonstrated by decreases in both Ki67 and pHH3-positive cardiomyocytes ( Figure 2F-I) . Additionally, we analysed cardiomyocyte apoptosis from E10.5 to E12.5 by both terminal dUTP nick end-labelling (Tunel) assay and cleaved-caspase3 expression level and found no significant differences between control and Nkx2.5 Cre/þ ; Ggpps fl/fl hearts (see Supplementary material online, Figure S6 ). Thus, these results indicated that the cardiac inactivation of Ggpps by Nkx2.5 Cre/þ arrested ventricular chamber growth through decreasing cardiomyocyte proliferation rather than increasing cardiomyocyte apoptosis. Besides the cardiomyocyte proliferation, proper differentiation of trabecular and compact myocardium also contributes to the ventricular chamber maturation. We next examined several genes differentially expressed in trabeculae, including Nppa, 30 Bmp10
31
, and Myl7
32
. In hearts from control group, our IHC results showed that NPPA and BMP10 expression became restricted to the trabecular component after E10.5 and E12.5, respectively, whereas MYL7 expressed in the both trabecular and compact region from E10.5 to E15.5 ( Figure 3A and see Supplementary material online, Figure S7A and B). Thus, NPPA is differentially expressed in the trabecular region earlier than BMP10. Notably, although the NPPA positive area was similar between control and 
Nkx2.5
Cre/þ ; Ggpps fl/fl hearts, an obvious ectopic expression of NPPA was observed in the left ventricular compact zone of mutant hearts at E11.5 and E12.5 ( Figure 3A and B) . Besides the ectopic expression, the mRNA and protein expression levels of Nppa were increased in mutant hearts at E11.5 ( Figure 3C-E) . Therefore, we compared the mRNA expression level of several upstream activators of Nppa 30 between control and Nkx2.5 Cre/þ ; Ggpps fl/fl hearts at E11.5 and found that Gata4 and Tbx5
were significantly increased in mutant hearts, whereas the expression levels of Nkx2.5 and Mef2c were not significantly different ( Figure 3C ).
For BMP10 and MYL7, we found their expression patterns were indistinguishable between control and Nkx2.5 Cre/þ ; Ggpps fl/fl hearts at E11.5 and E12.5 (see Supplementary material online, Figure S7C and D, S7G-I). Additionally, we also examined the expression pattern of compact myocardium markers, Hey2 and Mycn. While Hey 2 had a reduced expression level and lost its distribution in the compact myocardial nuclei in Nkx2. (n = 11 for E11.5, n = 9 for E12.5) hearts at E11.5 and E12. 5 . Scale bar: 50 lm. Quantification of HEY2 positive nuclei in the left ventricle (including trabecular and compact zone) was shown in (G). Data were presented as the mean ± SEM in this figure. *, P < 0.05; NS: Not significant; by unpaired two-tailed Student's t-test in this figure. . 
Later cardiac inactivation of Ggpps by a-SMA-Cre did not affect embryonic heart development
Surprisingly, a-SMA-Cre; Ggpps fl/fl progeny were born at the expected Mendelian frequency ( Figure 4A and see Supplementary material online, Table S2 ). Timed matings, genotyping and morphological analysis of embryos also showed that a-SMA-Cre; Ggpps fl/fl and control embryos were indistinguishable at E13.5, E15.5, and E17.5 ( Figure 4B) . Further histological analysis of sections showed that the interventricular septum, compact zone, and trabeculae of mutant hearts developed normally compared to control hearts at E13.5, E15.5, and E17.5 ( Figure 4C-F) . Additionally, by E15.5, Ki67, and pHH3 staining did not show a significant difference in the proliferation rate between control and mutant hearts ( Figure 4G and H). However, the survival of a-SMA-Cre; Ggpps fl/fl mice developed cardiac hypertrophy and all of them died by 10 weeks due to heart failure (see Supplementary material online, Figure S8 ), which was similar to the phenotype of a-MyHC-Cre; Ggpps fl/fl mice that we reported on previously. 25 These results suggested that cardiac inactivation of
Ggpps by a-SMA-Cre did not affect the heart development after the late stage of mid-gestation, but led to cardiac hypertrophy growth at the post-natal stage instead.
Mid-gestational disruption of protein geranylgeranylation led to the disorganization of cardiac cytoarchitecture
Previous studies showed that embryos with improper regional myocardial genes expression could survive to the perinatal stage. 32, 33 Additionally, severe cardiac growth arrest was only observed in dying Nkx2.5 Cre/þ ; Ggpps fl/fl embryos (E12.5). We, therefore, hypothesized that an alternative phenotype led to the comparatively early lethality seen in Nkx2.5 Cre/þ ; Ggpps fl/fl embryos. Interestingly, when we stained control and Nkx2.5 Cre/þ ; Ggpps fl/fl hearts with cardiac troponin T (cTnT), we found that the cardiomyocytes in the compact zone of mutant hearts became round and disorganized after E10.5 ( Figure 5A) . The immunostaining of a-SMA, another cytoskeletal protein highly expressed in embryonic cardiomyocytes, showed similar results to the cTnT staining ( Figure 5B) . These results indicated that the organization of the cytoskeleton was disrupted in Nkx2.5 Cre/þ ; Ggpps fl/fl cardiomyocytes. To further confirm the morphological changes in Ggpps-deficient ardiomyocytes, we analysed the ultrastructure of Nkx2.5 Cre/þ ; Ggpps fl/fl hearts at E11.5; and E12.5 using transmission electronic microscopy. At E11.5, the sarcomeres appeared to be distorted and compressed in mutant hearts ( Figure 5C ) with decreased sarcomere length [1.83 ± 0.06 lm in controls vs. 1.45 ± 0.10 lm in mutants, P < 0.05] ( Figure 5D ), which reflected a loss of myofibril tension. Moreover, 18/20 intercellular junction area with reduced electronic density were observed in E11.5 mutant hearts ( Figure  5E ), which indicated the loose cell-cell contact. More severe defects were also observed in the mutant hearts at E12.5 (see Supplementary material online, Figure S9 ). These observations suggested that GGPPSmediated protein geranylgeranylation was required for normal organization of cardiac cytoarchitecture during mid-gestation.
Protein geranylgeranylation was essential for cell-cell junctions in cardiomyocytes during mid-gestation
The establishment of cardiac cytoarchitecture was dependent on the formation of cell-cell junctions, such as adherens junctions, which are essential for heart development during embryonic stages. 7 As shown in Supplementary material online Figure S10 , GGTI (Sigma, #G5294), an inhibitor of geranylgeranyltransferase I, could delay the re-formation of adherens junctions in HeLa cells after EGTA treatment, which suggested the critical role of the geranylgeranylation in cell adhesion. We further found that cardiomyocytes isolated from E11.5 Nkx2.5 Cre/þ ; Ggpps fl/fl hearts had a reduced capacity of spreading and adhesion (see Supplementary material online, Figure S11 ). When we stained N-cadherin and its interactional protein b-catenin, we found that their expression weakened on the cell-cell contact areas and increased in the cytoplasm in E11.5 Nkx2.5 Cre/þ ; Ggpps fl/fl hearts ( Figure 6A ). However, the expression level of N-cadherin and b-catenin did not show significant differences between the control and Nkx2.5 Cre/þ ; Ggpps fl/fl hearts at E11.5
( Figure 6B ), whereas the interaction of these molecules declined markedly, as shown by co-immunoprecipitation analysis ( Figure 6C) . In addition to adherens junctions, gap junctions are essential for the electrical coupling of cardiomyocytes, and the cellular localization of these junctions is dependent on adherens junctions. 34, 35 We found that Connexin43 (Cx43), one of the components of gap junctions, could not form plaques between the cardiomyocytes in Nkx2.5 Cre/þ ; Ggpps fl/fl hearts, and most of the Cx43 protein was accumulated in the cytoplasm ( Figure 6D) . Furthermore, in Nkx2.5 Cre/þ ; Ggpps fl/fl hearts, the protein expression level of Cx43 increased while its mRNA expression level did not change significantly, which also reflected the trafficking and membrane localization defects of Cx43 in the mutant hearts ( Figure 6E and F) . Collectively, these observations supported that GGPPS mediated protein geranylgeranylation played an essential role in maintaining the normal structure of cell-cell junctions during mid-gestation.
Mid-gestational disruption of protein geranylgeranylation disturbed cardiac cytoarchitectural establishment by inhibiting Rho GTPase activity
Geranylgeranylation-dependent small GTPases, including Rho GTPases, were reported to regulate the cadherin-mediated cell-cell adhesion. [14] [15] [16] RhoA and Rac1, two representative members of Rho GTPases, had the similar expression level between E10.5 control and Nkx2.5 Cre/þ ; Ggpps fl/fl hearts (see Supplementary material online, Figure S12 ). However, Triton-X114 extraction analysis showed that hydrophobic RhoA and Rac1 (membrane bound form) were significantly decreased in mutant hearts at both E10.5 and E11.5 ( Figure 7A and B) , which suggested that the geranylgeranylation of RhoA and Rac1 decreased in Nkx2.5 Cre/þ ; Ggpps fl/fl hearts. Furthermore, we used anti-prenyl antibody (recognize both farnesyl and geranylgeranyl) to pull down the prenylated proteins and found that the prenylated RhoA and Rac1 were significantly reduced in the Nkx2.5 Cre/þ ; Ggpps fl/fl hearts compared with control hearts at E10.5 ( Figure 7C and D) . As expected, the enzymatic activity of RhoA and Rac1 markedly declined in Nkx2.5 Cre/þ ; Ggpps fl/fl hearts as early as E10.5
( Figure 7E) . To further confirm the role of geranylgeranylated small GTPase in the establishment of cardiac cytoarchitecture, we next tested whether elevating the protein geranylgeranylation level could rescue the Ggpps deficiency induced defects. As shown in Supplementary material
Protein geranylgeranylation regulates mammalian heart development Figure S13A , the declined protein geranylgeranylation in cultured E11.5 Nkx2.5 Cre/þ ; Ggpps fl/fl hearts was recovered after administration of GGPP (20 lM) in culture medium. As expected, the round cardiomyocytes and cell cluster number were significantly decreased and increased in GGPP treated Nkx2.5 Cre/þ ; Ggpps fl/fl cardiomyocytes compared to vehicle treated Ggpps deficient cardiomyocytes ( Figure 7F-G) . Moreover, maternal administration of GGOH (which could be converted to GGPP) (150 mg/kg/day) by intraperitoneal injection from E8.5 to E10.5 markedly recover the protein geranylgeranylation in Nkx2.5 Cre/þ ; Ggpps fl/fl heart at E11.5 (see Supplementary material online, Figure S13B ).
Meanwhile, disorganized cardiac cytoarchitecture and disrupted adherens junctions were partially restored in GGOH treated mutant hearts at E11.5 ( Figure 7H ). Taken together, these observations supported that GGPP-mediated protein geranylgeranylation facilitated the cardiac cytoarchitectural establishment during mid-gestation by maintaining small GTPase activity, including Rho GTPases.
Discussion
Following gastrulation and turning, the heart is the first definitive organ formed in embryos during mid-gestation. Meanwhile, the placenta gradually matures and provides embryos with more oxygen and nutrition. Actually, it has been reported that growth substrates provided by the placenta possibly act as developmental signals to facilitate developmental transitions during mid-gestation. For instance, oxygen and glucose could maintain epicardial Igf2 expression during mid-gestation to promote cardiomyocyte proliferation. 36 In our study, we found that cardiac Ggpps gene expression was increased after E10.5 when the placenta became functional. Although the effect of placenta activity on the cardiac Ggpps expression remains to be further studied, this finding suggests that there is a requirement of GGPPS and GGPPS mediated protein geranylgeranylation for mouse heart development during mid-gestation. Notably, previous studies of invertebrates and lower vertebrates revealed that protein prenylation was required in the early stages of heart development. 23, 24 However, to date there is no genetic evidence for the exact function of protein prenylation in mammalian embryonic heart development. In this study, we generated a cardiac Ggpps specific deficient mouse model and clarified the critical role of GGPPS-mediated protein geranylgeranylation in the ventricular chamber maturation and the organization of developing cardiomyocyte. An interesting finding from our present study was the identification of a critical period for protein geranylgeranylation in mammalian heart development. We noted that the early disruption of protein geranylgeranylation (at least from E9.5 onwards) by Nkx2.5 Cre/þ would led to lethal cardiac malformations, but not later disruption (from E13.5 onwards) by a-SMA-Cre. Moreover, although protein geranylgeranylation had been disrupted in E9.5 Nkx2.5 Cre/þ ; Ggpps fl/fl hearts, obvious cardiac defects, including aberrant cell proliferation, abnormal regional myocardial genes expression, and disorganized cytoarchitecture, were detectable until E11. 5 . Therefore, we propose that protein geranylgeranylation is indispensable for mouse heart development between E10.5 and E13. 5 . 7 Moreover, cadherin-mediated adherens junctions maintain not only the mechanical connections between cardiomyocytes but also the gap junction complex at the cell membrane. 37 The disruption of adherens junctions in embryonic or adult hearts have been reported to cause embryonic lethality or sudden arrhythmic death, respectively, 8, 38, 39 implying the critical role of adherens junctions in heart development and cardiac function. In the present study, cadherinmediated adherens junctions was disrupted in Nkx2.5 Cre/þ ; Ggpps fl/fl hearts as early as E11.5 and the abnormal gap junction was also observed at the same stage. Therefore, we suggested that the disruption of protein geranylgeranylation impaired cardiac function by affecting both mechanical and electrical coupling of cardiomyocytes and finally led to heart failure, which might explain the sudden death of mutant embryos from E12.0 and E13.0. Besides impairing the cardiac function directly, aberrant cardiac cytoarchitecture possibly contributes to the other abnormalities in Nkx2.5 Cre/þ ; Ggpps fl/fl hearts. For example, mitotic progression involves dynamic modulation of cell shape and morphology through remodelling of the actin and microtubule cytoskeletons. 40 Thus, we speculate that
Ggpps deficiency induced disorganization of cytoarchitecture may arrest the mitotic progression of cardiomyocytes, which causes a reduction of pHH3 positive cardiomyocytes in mutant hearts from E11. 5 . Since Ki67 expresses in all active phases of the cell cycle (G1, S, G2, and M), the cardiomyocytes that arrested before M phase could still be stained by Ki67, which may explain the inconsistent results of the pHH3 and Ki67 staining in E11.5 Nkx2.5 Cre/þ ; Ggpps fl/fl hearts. In addition, N-cadherin has been reported to regulate the process of cardiac trabeculation and trabecular regional specification. [41] [42] [43] Thus, Ggpps deficiency induced abnormal N-cadherin expression pattern may contribute to the defect of trabecular regional specification in mutant hearts. Critical role of Rho GTPases, including RhoA, Rac1, and Cdc42, in cadherin-mediated cell-cell adhesion has been widely studied. 15 Additionally, the other geranylgeranylation-dependent small GTPases, such as Rap1, Rab5, and Rab11, are also reported to regulate the cadherin-mediated cell-cell adhesion. 44, 45 Thus, besides the inactivation of RhoA and Rac1 that we observed in the present study, Ggpps deletion induced aberrant functions of Rap1 and Rab GTPases are also possibly responsible for the defects of cell-cell junctions in Nkx2.5 Cre/þ ; Ggpps fl/fl hearts. Since the crucial role of geranylgeranylation-dependent small GTPases in cell-cell adhesion, why are they only indispensable in a specific time window after the onset of placental function? It should be noted that cardiomyocytes are subjected to stronger stretching after Figure 8 Proposed mechanism of the regulation of ventricular chamber maturation by GGPPS mediated protein geranylgeranylation. Farnesyl pyrophosphate (FPP) and geranylgeranylpyrophosphate (GGPP) are two type of isoprenoid derived from mevalonate pathway. Geranylgeranylpyrophosphate synthase (GGPPS) catalyzes FPP into GGPP which serves as the substrate for GGTase I to regulate the geranylgeranylation of Rho GTPase. The activated Rho GTPase maintains cell-cell junction to facilitate the organization of cardiomyocytes. Well-organized cardiac cytoarchitecture is critical for the morphology remodelling and heart function during ventricular chamber maturation. Cardiac loss of GGPPS inhibits the activity of Rho GTPase through decreasing geranylgeranylation. The inactivated Rho GTPase is unable to facilitate the maturation of cell-cell junctions and leads to the disorganization of cytoarchitecture after E10.5, which impair the ventricular chamber maturation and ultimately result in embryonic lethality around E12.5.
